Stocks
Arcturus Therapeutics Holdings (ARCT) EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -71.8 | -200.4 | 11.7 | -75.1 | -1.20 | -70.2 | ||
| Changes by years, y/y, % | +181% | +179% | -106% | -744% | -98% | -43.6% | |||
Arcturus Therapeutics Holdings. EBITDA US GAAP, bln rub
Arcturus Therapeutics Holdings. EBITDA US GAAP, changes, %
Arcturus Therapeutics Holdings. EBITDA US GAAP, sum by quarters, bln rub
Arcturus Therapeutics Holdings (ARCT) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -51.4 | -19.3 | -15.1 | -10.3 | -25.5 | -70.2 | |
| Changes by years, y/y, % | +137% | -46% | -112% | -108% | +35% | |||
| Changes by quarters, q/q, % | +172% | -62% | -22% | -32% | +148% | |||
